gracellbio.com | 亘喜生物 | 引领下一代 CAR-T

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔

Meta Tags

Title	亘喜生物 \| 引领下一代 CAR-T
Description	亘喜生物 \| 引领下一代 CAR-T
Keywords	引领下一代 CAR-T 细胞疗法

Server Information

WebSite	gracellbio.com
Host IP	112.53.1.229
Location	China

Related Websites

                        Site
                        Rank
                    

More to Explore

gracellbio.com Valuation

US$9,726,361

Last updated: 2023-05-02 17:37:32

gracellbio.com has Semrush global rank of 1,088,208. gracellbio.com has an estimated worth of US$ 9,726,361, based on its estimated Ads revenue. gracellbio.com receives approximately 1,122,273 unique visitors each day. Its web server is located in China, with IP address 112.53.1.229. According to SiteAdvisor, gracellbio.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$9,726,361
Daily Ads Revenue	US$8,979
Monthly Ads Revenue	US$269,346
Yearly Ads Revenue	US$3,232,145
Daily Unique Visitors	74,819
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
gracellbio.com.	A	600	IP: 112.53.1.229
gracellbio.com.	A	600	IP: 121.14.78.67
gracellbio.com.	AAAA	598	IPV6: dnspod-vip4.beian.mydnspod.net.
gracellbio.com.	NS	597	NS Record: dnspod-vip4.beian.mydnspod.net.
gracellbio.com.	MX	600	MX Record: 5 mxpro01.yovocloud.com.
gracellbio.com.	MX	600	MX Record: 5 mxpro02.yovocloud.com.
gracellbio.com.	TXT	596	TXT Record: dnspod-vip4.beian.mydnspod.net.

HtmlToTextCheckTime:2023-05-02 17:37:32

亘喜生物 | 引领下一代 CAR-T 细胞疗法关于亘喜公司简介管理团队董事会技术和平台技术方略 FasTCAR平台 TruUCAR平台 SMART CART 生产制造产品管线新闻中心公司新闻媒体报道招贤纳士 | EN 中文引领下一代 CAR-T 细胞疗法亘喜生物专注研发细胞与基因疗法，为癌症患者带来快速、深入且持久的治疗效果了解更多我们的使命亘喜生物科技集团是一家致力于开发高效、经济的细胞疗法用于癌症治疗的全球临床阶段生物制药公司。我们以攻克当前行业重大挑战为己任，努力解决癌症疾病领域迫切的临床需求。利用自主研发的、开创性FasTCAR和TruUCAR两大技术平台以及SMART CART TM 技术模块，亘喜生物力求革新传统CAR-T细胞疗法。 FasTCART ™ 亘喜生物的自体 CAR-T 细胞技术平台，可实现次日完成生产，并提供细胞表型更年轻、扩增及肿瘤细胞清除活性更强的 CAR-T 细胞 TruUCART ™ 亘喜生物的通用型同种异体CAR-T细胞技术平台，能够以更低成本为广大患者提供即需即用的细胞疗法 SMART CART ™ 亘喜生物第二代增强型CAR-T技术模块，针对性攻克实体瘤治疗的重重挑战产品管线我们正在着力推进和拓展临床阶段产品管线，力求实现CAR-T 细胞疗法的巨大潜力最新要闻 2023 年 4 月 26 日亘喜生物将在2023 ASCO年会期间公布BCMA/CD19双靶点FasTCAR-T GC012F的最新临床数据 2023 年 2 月 13 日再传捷报！亘喜生物FasTCAR-T GC012F疗法的1/2期新药临床试验（IND）申请获中国国家药品监督管理局批准，评估治疗复发/难治性多发性骨髓瘤 2023 年 2 月 03 日亘喜生物宣布FasTCAR-T GC012F疗法的1b/2期新药临床试验（IND）申请获美国FDA正式批准，用于治疗复发/难治性多发性骨髓瘤条款与条件隐私政策联系我们招贤纳士 © 2021 亘喜生物。保留所有权利。

HTTP Headers

HTTP/1.1 301 Moved Permanently
Server: DNSPod URL V2.0
Content-Length: 0
Connection: close
Date: Mon, 25 Oct 2021 02:32:23 GMT
Cache-Control: max-age=600
Expires: Mon, 25 Oct 2021 02:42:23 GMT
Location: https://www.gracellbio.com

HTTP/2 200 
content-type: text/html
content-length: 23921
date: Mon, 25 Oct 2021 02:32:25 GMT
last-modified: Sun, 24 Oct 2021 22:11:40 GMT
etag: "7a4f6bacdaa3d3361ecbfdb938105a7b"
x-amz-server-side-encryption: AES256
accept-ranges: bytes
server: AmazonS3
cache-control: public, max-age=0, s-maxage=2
vary: Accept-Encoding
x-cache: Miss from cloudfront
via: 1.1 80c3f3f64b353aee8087c562e4ffa811.cloudfront.net (CloudFront)
x-amz-cf-pop: ORD53-C2
x-amz-cf-id: 9ozh3-IVLyW7qfXrdLhsbXmPRtWodB64CfynToGWB6CNwXUdzMILkw==

gracellbio.com Whois Information

Domain Name: GRACELLBIO.COM
Registry Domain ID: 2135086530_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.paycenter.com.cn
Registrar URL: http://www.xinnet.com
Updated Date: 2019-04-22T09:29:45Z
Creation Date: 2017-06-19T07:20:49Z
Registry Expiry Date: 2027-06-19T07:20:49Z
Registrar: Xin Net Technology Corporation
Registrar IANA ID: 120
Registrar Abuse Contact Email: supervision@xinnet.com
Registrar Abuse Contact Phone: +86.4008182233
Domain Status: ok https://icann.org/epp#ok
Name Server: NS3.DNSV4.COM
Name Server: NS4.DNSV4.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-13T07:29:14Z <<<

gracellbio.com valuation and analysis